Patent Assignment
Reel/Frame 061955/0033
Change of Name
Recorded: 2022-11-16
Pages: 2
Assignor
BENITECH BIOPHARMA LIMITED
Executed: 2020-08-14
Assignee
BENITEC BIOPHARMA PTY LTD
SUITE 1201, 99 MOUNT STREET, NORTH SYDNEY, NEW SOUTH WALES, 2060, AUSTRALIA
Covered Properties
(4)
Reagents for Treatment of Hepatitis B Virus (Hbv) Infection and Use Thereof
REAGENTS FOR PRODUCING T-CELLS WITH NON-FUNCTIONAL T-CELL RECEPTORS (TCRs) COMPOSITIONS COMPRISING SAME AND USE THEREOF
Application:
16/333,133 →
Publication:
US 2019/0309307
Reagents for Treatment of Hepatitis B Virus (Hbv) Infection and Use Thereof
Application:
17/124,066 →
Publication:
US 2021/0177885
Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD)
Application:
17/285,569 →
Publication:
US 2022/0106594
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 27, 2018
From: MAO, TIN; SUHY, DAVID
To: BENITEC BIOPHARMA LIMITED
Reel/Frame 047585/0747 →
Assignment of Assignor's Interest
Jul 28, 2020
From: GARCIA, PATTY BERTHA; STRINGS-UFOMBAH, VANESSA; ROELVINK, PETRUS W.; SUHY, DAVID
To: BENITEC BIOPHARMA LIMITED
Reel/Frame 053327/0352 →
Assignment of Assignor's Interest
Jan 6, 2021
From: MAO, TIN; KAO, SHIH-CHU; SUHY, DAVID; GRAHAM, MICHAEL
To: BENITEC BIOPHARMA LIMITED
Reel/Frame 054827/0490 →
Assignment of Assignor's Interest
Apr 19, 2021
From: STRINGS-UFOMBAH, VANESSA; SUHY, DAVID
To: BENITEC BIOPHARMA LIMITED
Reel/Frame 055958/0344 →
Assignment of Assignor's Interest
Jul 14, 2021
From: BENITEC BIOPHARMA PTY LTD ACN
To: BENITEC IP HOLDINGS, INC.
Reel/Frame 056856/0134 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 056856 Frame: 0134. Assignor(S) Hereby Confirms the Assignment .
Jan 12, 2022
From: BENITEC BIOPHARMA PTY LTD ACN
To: BENITEC IP HOLDINGS INC.
Reel/Frame 058703/0585 →
Corrective Assignment to Correct the Conveying Party Name Previously Recorded at Reel: 058703 Frame: 0585. Assignor(S) Hereby Confirms the Assignment.
Dec 27, 2022
From: BENITEC BIOPHARMA PTY LTD
To: BENITEC IP HOLDINGS INC.
Reel/Frame 062221/0160 →